Home » Agenda » Day 1

Day 1

Personalised Medicine World Congress 2022 Europe

Barcelona, Spain

Monday 30th May 2022

CHALLENGES & TRENDS IN THE DEVELOPMENT OF PERSONALISED MEDICINE

  • Importance of individual and public engagements
  • New skills for healthcare professionals and novel tools for delivery
  • What must be done for the successful implementation of PM in all perspectives?
  • The use of health related data
  • How to develop sustainable economic models that allow improved therapy, diagnostic and preventive approaches as new healthcare concepts for the benefit of the public?
  • How can personalised medicines revolutionise the traditional healthcare and treatment approach?
  • To exploit the benefits of personalised medicines, what challenges must be addressed?
  • Implementation of the precision medicine approach to design highly targeted therapeutic drugs
  • At this stage, is awareness and education amongst all the stakeholders and regulatory support from governing bodies as well as policymakers enough to progress?
  • Benefit, risk evaluation and regulatory decision making
  • Emerging new clinical trials design
  • Use of data derived from several independent studies
  • HTAs acceptance
  • How to prepare for and adopt rapid shifts in regulations related to personalized health care?
  • How to streamline regulatory processes to reduce unnecessary burdens associated with regulatory activities
  • Advantages of taking a data-centric approach
  • What are the life-changing potential of  personalised medicine in improving health outcomes?
  • What are the role of clinical research in facilitating personalised medicine development?
  • Best practices and lessons learned for timely access to the targeted population

TECHNOLOGIES, INNOVATIONS & CLINICAL TRIALS

  • Advancements in wearable and digital therapies
  • Universal adoption and accessibility of wearable and digital technology
  • What are the major drawbacks and areas for improvement?
  • Addressing issue in privacy protection: data generated or stored by commercial wearables.
  • Astonishing potential of AI in assisting clinical decision making and revolutionizing the field of health care.
  • Different sources of biases for machine learning algorithms
  • Tools that can help address biases in AI
  • Current challenges in next generation sequencing
  • What are the key benefits of Comprehensive genetic profiling?
  • Integrating comprehensive genomic profiling into real-world setting
  • Design and clinical impact of innovative comprehensive genomic profiling clinical trials
  • The pivotal role of epigenetic mechanisms in health and diseases
  • State-of-the-art epigenetic IVD tests and epigenetic drugs which are presently being established in clinical trials.
  • How epigenetic technology will support the incorporation of precision medicine in clinical settings?
  • Defining decentralized clinical trials and understanding their nuances
  • Engaging with various stakeholders early in the process
  • The importance of physicians involvement in performing the much-needed test and checks that technology alone cannot handle
  • Upcoming therapies, technologies and treatments that will enhance all aspects of patient care
  • Analytics that reduced cost to patients
  • New technology demands unified security models
  • Real-time digital integration, hospital-wide AIs, and smart medical facilities
  • Decentralized clinical trial strategies to fully integrate every aspect of the available new tech.
Scroll to Top